Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Oncology
  • Oncology News
  • New biomarker shows...

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer: Study

Dr. Kamal Kant KohliWritten by Dr. Kamal Kant Kohli Published On 2024-08-01T20:30:38+05:30  |  Updated On 1 Aug 2024 8:31 PM IST
New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer: Study
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Colorectal cancer is the second leading cause of cancer deaths worldwide and the third most diagnosed cancer, affecting over a million people annually. The problem worsens if the tumour is metastatic, meaning it moves from the original organ to other parts of the body. In this scenario, the five-year survival rate drops from 70-90% to just 10%.

While some subgroups of colorectal cancer patients are beginning to have new therapeutic options, the vast majority of metastatic patients still follow conventional treatments, typically involving chemotherapy with biological agents. Initially effective, these treatments often encounter resistance over time, leading to inevitable disease progression.

Proteins with potential to measure treatment response

Researchers at the Can Ruti Campus, collaborating through the CARE and ProCURE programmes of IGTP and Institut Català d’Oncologia (ICO) respectively, have been searching for reliable biomarkers for years to select the best therapeutic option for each patient. Their research has led them to study chemokines, small proteins secreted by tumour cells that attract other cells from the immune system.

They focused on the CXC family, which plays an important role in pathological processes in cancer by modifying the tumour microenvironment. Previous results in cell models indicate that high secretion of these proteins is associated with resistance to oxaliplatin, one of the most used chemotherapies in this neoplasm.

Thus, the authors of the study published in Biomedicine & Pharmacotherapy analysed the blood of 104 patients with metastatic colorectal cancer undergoing oxaliplatin-based treatment. They collected serum samples before treatment, during response evaluation, and at disease progression or the last follow-up visit, and analysed possible changes and their relationship with treatment response and prognosis. This approach with blood samples is more comprehensive than other methods that only analyse part of a lesion. Additionally, it is a non-invasive and time-specific sample extraction method.

The chemokine CXCL13 shows promising results

The study examined 11 CXC chemokines. The researchers observed that first-line oxaliplatin-based treatment causes changes in the levels of these proteins. One of them, CXCL13, stands out because it shows a different behaviour: increasing levels are associated with a positive treatment response and improved survival, while a decrease is associated with non-response and poorer prognosis.

Dr Eva Martínez Balibrea, leader of the Resistance, Chemotherapy, and Predictive Biomarkers (RCPB) group at IGTP and ICO, explains the significance of this finding: "CXCL13 is an opportunity to measure the response to oxaliplatin chemotherapy in a minimally invasive way using simple techniques that can be used by any clinical laboratory." She adds, "This is the first study to show a correlation between serum CXCL13 and prognosis in patients with colorectal cancer treated with oxaliplatin." It is important to note that oxaliplatin is quite toxic, often causing patients to abandon treatment: "Having a tool that allows us to choose the treatment will also help avoid unnecessary toxicities and improve the quality of life for patients."

The authors obtained comparable results using computational data from a similar patient group. In this other analysis, they also observed the correlation between CXCL13, the presence of tertiary lymphoid structures - aggregates of immune cells formed in chronic inflammation sites, including tumours - and the correlation of both with prognosis.

Martínez-Balibrea is cautious considering it is a study in a specific cohort of patients, but she is optimistic about the future: "We are making progress in the search for predictive and prognostic markers. Finding a potential biomarker with non-invasively extracted samples is great news. We will continue this line of research in future studies."

Reference:

Sara Cabrero-de las Heras, Xavier Hernández-Yagüe, Andrea González, Ferran Losa, Gemma Soler, Cristina Bugés, Iosune Baraibar, Anna Esteve, Miguel Ángel Pardo-Cea, Anne Hansen Ree, Neus Martínez-Bosch, Maria Nieva, Eva Musulén, Sebastian Meltzer, Tania Lobato, Carla Vendrell-Ayats, Cristina Queralt, Pilar Navarro, Clara Montagut, Ferran Grau-Leal, David Camacho, Raquel Legido, Núria Mulet-Margalef, Eva Martínez-Balibrea, Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment, Biomedicine & Pharmacotherapy, https://doi.org/10.1016/j.biopha.2024.116857.

Biomedicine & Pharmacotherapycolorectal cancercancer
Source : Biomedicine & Pharmacotherapy
Dr. Kamal Kant Kohli
Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

Show Full Article
Next Story

Editorial

First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

Aspirin in Primary Prevention- When to Consider?

Aspirin in Primary Prevention- When to Consider?

View All

Journal Club Today

Is Fitness Overrated? Study Questions the True Impact of Fitness on Early Death

Is Fitness Overrated? Study Questions the True Impact of Fitness on Early Death

View All

Health News Today

Health Bulletin 17/ May/ 2025

Health Bulletin 17/ May/ 2025

View All
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok